StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker MedSurg & Neurotechnology by Year

MedSurg & Neurotechnology — Organic Net Sales Growth YoY (%) (%)

Stryker MedSurg & Neurotechnology: 10.7% in FY2025, down 0.5 pts from a year earlier.

Latest, FY2025
10.7%
Period ended Dec 31, 2025
Change on a year earlier
-0.5 pts
11.2% in FY2024
History
4 years
Since FY2022
Sources
4
Documents cited below

Where the FY2025 figure comes from

Reported in Stryker Form 8-K & Form 10-K/10-Q MD&A.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMedSurg & Neurotechnology — Organic Net Sales Growth YoY (%) (%)Year on yearSource
FY2025Dec 31, 202510.7%-0.5 pts0000310764-26-000006|sykex991earningsq42025.htm ↗
FY2024Dec 31, 202411.2%-0.6 pts0000310764-25-000005|sykex991earningsq42024.htm ↗
FY2023Dec 31, 202311.8%0.0 pts0000310764-24-000005|sykex991earningsq42023.htm ↗
FY2022Dec 31, 202211.8%–0000310764-23-000005|sykex991earningsq42022.htm ↗

Breakdown

What makes up medSurg & Neurotechnology

Cite this data

StockData. (2026). Stryker MedSurg & Neurotechnology (%), annual FY2022–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-medsurg-org

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.